Evidence map›Paper›PMID 41426172›Full record

ArticleSouth Asian journal of cancer2025

Copy Number Alteration of Cyclin D1 (CCND 1) Gene as a Prognostic Factor in Oral Squamous Cancers and its Correlation with Immunohistochemistry (IHC).

Ranganath Ratnagiri, Shubhranshu Jena, Prajnya Ranganath, Megha S Uppin, Rajashekar Shantappa

Abstract read
In one paragraph

Article in South Asian journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ranganath RatnagiriDepartment of Surgical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.ORCID 0000-0002-3267-0514
Shubhranshu JenaDepartment of Surgical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
Prajnya RanganathDepartment of Medical Genetics, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.ORCID 0000-0001-7122-3197
Megha S UppinDepartment of Pathology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.
Rajashekar ShantappaDepartment of Surgical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral squamous cancers remain the most common cancers among males in India and the third most common cancer among men and women combined, with an age standardized ratio of 9.1 per 100,000 population. Surgery and chemoradiation have not improved survival rates significantly and hence, newer therapeutic targets are needed. Cyclin D1 ( Aim: This article correlates cyclin D1 ( Materials and Methods: Sixty-three patients who underwent surgery for oral cancer between January and June 2022 were included in the study after obtaining informed consent and ethics approval. Copy number alteration of CCND1 was assessed using quantitative polymerase chain reaction (Qf PCR) and correlated with clinical and histopathological prognostic factors, including short-term recurrence. Statistical analysis was performed using the SPSS software. Results: A statistically significant correlation was determined between the Qf PCR values of CCND1 gene and locoregional recurrence. Gene copy number alteration also correlated strongly with a higher grade of the primary tumor. There was also a significant correlation between the Qf PCR values and the immunohistochemistry for cyclin D1. Conclusion: Cyclin D1 offers a new therapeutic target in oral cancers and may improve survival without significant treatment-related morbidity.

Indexed as

copy number alterationcyclin D1 geneimmunohistochemistryoral squamous cancersprognosisquantitative PCR

Identifiers

PMID41426172
PMCPMC12714465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.